search
Back to results

Digital Treatments for Opioids and Other Substance Use Disorders in Primary Care (DIGITS)

Primary Purpose

Drug Use Disorders, Illicit Drug Use, Alcohol-Related Disorders

Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Standard implementation
Health Coaching
Practice Facilitation
Sponsored by
Kaiser Permanente
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Drug Use Disorders focused on measuring substance use disorders, mHealth, digital therapeutics, primary care, implementation science, randomized controlled trial, factorial trial, opioid use disorders

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Patient Inclusion Criteria:

  • Had a primary care visit in a participating clinic during the active implementation period or sustainment period
  • Screened positive for substance use on the day of the visit or in the prior year
  • Adult aged 18 years or older at time of visit

Clinic Inclusion Criteria:

- At least 1 clinician trained in the use of reSET/reSET-O

Patient Exclusion Criteria:

- Patients who have requested through their health system to opt out of research

Clinic Exclusion Criteria:

- Previously participated in a pilot implementation of reSET/reSET-O

Sites / Locations

  • Kaiser Permanente Washington

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Active Comparator

Experimental

Experimental

Experimental

Arm Label

Standard Implementation

Standard Implementation Plus Health Coaching

Standard Implementation Plus Practice Facilitation

Standard Implementation Plus Health Coaching and Practice Facilitation

Arm Description

All primary care clinics will implement reSET and reSET-O using standard implementation approach.

The clinics in this arm will implement reSET and reSET-O with a standard implementation strategy and patients at the clinic will receive support from a health coach to help them engage with reSET and reSET-O.

The clinics in this arm will implement reSET and reSET-O with a standard implementation strategy and a practice facilitator will provide the clinic with support for implementation.

The clinics in this arm will implement reSET and reSET-O with a standard implementation strategy and patients at the clinic will receive support from a health coach to help them engage with reSET and reSET-O. Additionally, a practice facilitator will provide the clinic with support for implementation.

Outcomes

Primary Outcome Measures

Reach of the digital therapeutic to patients in the primary care clinic
The proportion of patients who initiate the digital therapeutic, defined by instances in which patients open the app, enter the prescription code, and use a treatment module.
Fidelity of patients' use of the digital therapeutic to clinical recommendations
Mean number of weeks during patients' 12-week prescription in which patients use 4 app modules/week and have visited a clinician in the past 30 days

Secondary Outcome Measures

Engagement
Mean number of months in which patients make ≥1 visit for substance use disorder
Economic costs
Costs from the perspective of a health system and payer including implementation, direct intervention, operating, and other indirect health care costs. This measure will be used to calculate the population-level cost effectiveness of increasing reach, fidelity, and engagement.

Full Information

First Posted
December 3, 2021
Last Updated
May 5, 2023
Sponsor
Kaiser Permanente
Collaborators
National Institute on Drug Abuse (NIDA)
search

1. Study Identification

Unique Protocol Identification Number
NCT05160233
Brief Title
Digital Treatments for Opioids and Other Substance Use Disorders in Primary Care
Acronym
DIGITS
Official Title
Digital Treatments for Opioids and Other Substance Use Disorders (DIGITS) in Primary Care: A Hybrid Type-III Implementation Trial
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
December 9, 2021 (Actual)
Primary Completion Date
May 9, 2023 (Anticipated)
Study Completion Date
September 9, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Kaiser Permanente
Collaborators
National Institute on Drug Abuse (NIDA)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The DIGITS Trial addresses a critical knowledge gap: How to best implement digital treatments for opioids and other substance use disorders in primary care. The DIGITS Trial is a partnership between Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle, and Kaiser Permanente Washington, a healthcare delivery system in Washington State. In this study, the FDA-authorized reSET and reSET-O digital therapeutics will be implemented in Kaiser Permanente Washington primary care clinics. The study will evaluate the extent to which two implementation strategy interventions, health coaching and practice coaching, improve the implementation. Primary care clinics are randomized to receive these implementation strategy interventions. Each clinic will have a 12-month active implementation period beginning on its date of randomization. To study the continued use of reSET and reSET-O after the active implementation period is completed, a sustainment period of up 12 months will follow the active implementation period.
Detailed Description
Specific Aims of the DIGITS Trial are to: Estimate the effect of practice facilitation and health coaching implementation strategies in increasing the reach and fidelity of a digital therapeutic for substance use disorders in primary care clinics. Compare the population-level cost-effectiveness of each implementation strategy in increasing reach, fidelity, and abstinence.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Drug Use Disorders, Illicit Drug Use, Alcohol-Related Disorders, Opioid Use Disorder
Keywords
substance use disorders, mHealth, digital therapeutics, primary care, implementation science, randomized controlled trial, factorial trial, opioid use disorders

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Model Description
Cluster-randomized trial with 2x2 factorial randomization of two experimental strategies resulting in four arms: 2x2 factorial design to four approaches: (1) "standard implementation"; (2) "standard implementation plus practice facilitation"; (3) "standard implementation plus health coach"; and (4) "standard implementation plus both.
Masking
Outcomes Assessor
Masking Description
All outcomes are derived from secondary administrative data.
Allocation
Randomized
Enrollment
13000 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Standard Implementation
Arm Type
Active Comparator
Arm Description
All primary care clinics will implement reSET and reSET-O using standard implementation approach.
Arm Title
Standard Implementation Plus Health Coaching
Arm Type
Experimental
Arm Description
The clinics in this arm will implement reSET and reSET-O with a standard implementation strategy and patients at the clinic will receive support from a health coach to help them engage with reSET and reSET-O.
Arm Title
Standard Implementation Plus Practice Facilitation
Arm Type
Experimental
Arm Description
The clinics in this arm will implement reSET and reSET-O with a standard implementation strategy and a practice facilitator will provide the clinic with support for implementation.
Arm Title
Standard Implementation Plus Health Coaching and Practice Facilitation
Arm Type
Experimental
Arm Description
The clinics in this arm will implement reSET and reSET-O with a standard implementation strategy and patients at the clinic will receive support from a health coach to help them engage with reSET and reSET-O. Additionally, a practice facilitator will provide the clinic with support for implementation.
Intervention Type
Behavioral
Intervention Name(s)
Standard implementation
Intervention Description
Brief clinician training and an implementation toolkit consisting of job aids, patient educational materials, scripted conversations, electronic health record tools, and a population management workbench.
Intervention Type
Behavioral
Intervention Name(s)
Health Coaching
Intervention Description
The clinic is provided access to a health coach who conducts outreach with patients. The health coach facilitates engagement with the digital therapeutic and encourages contact with the care team.
Intervention Type
Behavioral
Intervention Name(s)
Practice Facilitation
Intervention Description
A trained facilitator provides support for implementation by delivering the following interventions to clinic staff: Bolster Education, Audit and Provide Feedback, Support Plan-Do-Study-Act Cycles, Engage Others in Change.
Primary Outcome Measure Information:
Title
Reach of the digital therapeutic to patients in the primary care clinic
Description
The proportion of patients who initiate the digital therapeutic, defined by instances in which patients open the app, enter the prescription code, and use a treatment module.
Time Frame
12 months
Title
Fidelity of patients' use of the digital therapeutic to clinical recommendations
Description
Mean number of weeks during patients' 12-week prescription in which patients use 4 app modules/week and have visited a clinician in the past 30 days
Time Frame
15 months
Secondary Outcome Measure Information:
Title
Engagement
Description
Mean number of months in which patients make ≥1 visit for substance use disorder
Time Frame
15 months
Title
Economic costs
Description
Costs from the perspective of a health system and payer including implementation, direct intervention, operating, and other indirect health care costs. This measure will be used to calculate the population-level cost effectiveness of increasing reach, fidelity, and engagement.
Time Frame
12 months
Other Pre-specified Outcome Measures:
Title
Reach-2
Description
The proportion of patients prescribed reSET or reSET-O
Time Frame
12 months
Title
Fidelity-2
Description
Mean number of weeks in which patients use at least 1 module/week
Time Frame
15 months
Title
Sustainment
Description
The proportion of patients who are reached during the sustainment period
Time Frame
12 months
Title
Substance use
Description
The proportion of patients who are reached and reduce their substance use
Time Frame
Up to 18 months from the patients index visit date
Title
Abstinence
Description
The proportion of patients who are reached and are abstinent from substances
Time Frame
Up to 18 months from the patients index visit date

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Patient Inclusion Criteria: Had a primary care visit in a participating clinic during the active implementation period or sustainment period Screened positive for substance use on the day of the visit or in the prior year Adult aged 18 years or older at time of visit Clinic Inclusion Criteria: - At least 1 clinician trained in the use of reSET/reSET-O Patient Exclusion Criteria: - Patients who have requested through their health system to opt out of research Clinic Exclusion Criteria: - Previously participated in a pilot implementation of reSET/reSET-O
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Joseph E Glass, PhD, MSW
Organizational Affiliation
Kaiser Permanente
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kaiser Permanente Washington
City
Seattle
State/Province
Washington
ZIP/Postal Code
98101
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Digital Treatments for Opioids and Other Substance Use Disorders in Primary Care

We'll reach out to this number within 24 hrs